About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

2 J. Pharmacy & L. 15 (1993)
Scientific Misconduct: A Form of White Coat Crime

handle is hein.journals/jpharm2 and id is 23 raw text is: SCIENTIFIC MISCONDUCT: A FORM OF WHITE COAT CRIME BY SANDY KLINE* I. INTRODUCTION The expenditures devoted to the health care industry in the United States have grown faster than expenditures for other types of goods and services.' Never before has technology and new drug development been as productive as it is today.2 Along with such growth comes increased pressures within the scientific community to do more, faster. Of course, in these economically challenged times, one must do so, and with fewer resources as a form of health care cost containment and reform.3 Increased competition for shrinking grant dollars and the never ending burden to publish or perish within the academic setting has pushed some researchers to cross the line and commit scientific misconduct.4 The question becomes: what price is society willing to pay for such advancements? Does any degree of patient morbidity associated with such misconduct constitute a reasonable risk? This paper will address the need to impose the currently available criminal sanctions upon those researchers guilty of scientific misconduct as a means to deter future misconduct and contain the spread of white coat crime. H. DEFINING MISCONDUCT, CONTRASTING MISTAKE Scientific misconduct or fraud in scientific research has been perceived and defined differently over the last few years by various scientific, * Sandra S. Kline, Pharm.D., Pharmacy Clinical Coordinator, Medical College Hos- pitals. 1. Patricia A. Ensor, Projecting Future Drug Expenditures - 1992, 49 AM J. HosprrAL PHARmACY 140, 145, 839 (1992) 2. See Joseph A. DiMasi et al., New Drug Development in the United States From 1963 to 1990, 50 CLINICAL PHARLAcoLoGy & THERAPEUTICS 471 (1991). 3. Philip R. Lee et al., Costs and Coverage: Pressure Toward Health Care Reform, 157 W. J. MED. 576 (1992); Jay Rockefeller, Health Care Reform: Prospects and Progress, 67 ACADEwMC MED. 141, 142 (1992). 4. See Richard Knox, The Harvard Fraud Case: Where Does the Problem Lie?, 249 JAMA 1797 (1983). The article describes a case of scientific misconduct at the Harvard Medical School in which a research fellow, John Roland Darsee, M.D., falsified animal research experiments and fabricated data in at least five Harvard research projects. Results of this data was published in nine papers he co-authored, as well as many abstracts, published and unpub- lished. The fabricated data played a major role in ultimately ruining a multicenter cooperative -study done under contract for approximately $700,000 with the National Heart, Lung and Blood Institute. Much of Darsee's previous work at Emory University, as well as the under- graduate projects he was involved with, is also under suspicion.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most